Holen Sie sich die Stockscreener-App
23.94
3.86%
-0.96
Vorhandelsmarkt:
23.80
-0.14
-0.58%
Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten
Centessa Pharmaceuticals stock hits 52-week high at 25.35 USD By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals stock hits 52-week high at 25.35 USD - Investing.com
Centessa Pharmaceuticals (CNTA) – Research Analysts’ Weekly Ratings Changes - Defense World
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025 - GlobeNewswire Inc.
Mario Alberto Accardi Sells 8,000 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - MarketBeat
Centessa Pharma (CNTA) president sells $200k in shares - Investing.com India
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month HighHere's What Happened - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at $24.65 - Investing.com India
Centessa Pharmaceuticals stock hits 52-week high at $24.65 By Investing.com - Investing.com Philippines
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Bought by Windmill Hill Asset Management Ltd - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Stake Reduced by GAMMA Investing LLC - Defense World
Centessa Pharmaceuticals (CNTA) Receives a Buy from Piper Sandler - The Globe and Mail
Tanager Wealth Management LLP Decreases Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Platinum Investment Management Ltd. Has $3.82 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Wells Fargo Sticks to Its Buy Rating for Centessa Pharmaceuticals (CNTA) - The Globe and Mail
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 12-Month HighWhat's Next? - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 24.17 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of “Buy” by Brokerages - Defense World
Centessa Pharmaceuticals stock hits 52-week high at 24.17 USD - Investing.com India
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 1-Year HighTime to Buy? - MarketBeat
Centessa Pharmaceuticals’ Bush sells $840,000 in shares - Investing.com India
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) CTO Sells $840,000.00 in Stock - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 12-Month HighHere's What Happened - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – Should You Buy? - Defense World
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 8,172 Shares of Stock - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 23.51 USD By Investing.com - Investing.com Australia
Centessa Pharmaceuticals (NASDAQ:CNTA) General Counsel Iqbal J. Hussain Sells 6,000 Shares - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 23.51 USD - Investing.com
Woodline Partners LP Lowers Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Ellsworth Advisors LLC Buys Shares of 48,872 Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Fred Alger Management LLC Has $2.11 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharma general counsel sells $131k in shares By Investing.com - Investing.com South Africa
Centessa Pharma general counsel sells $131k in shares - Investing.com India
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 1-Year HighShould You Buy? - MarketBeat
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):